Neurologic AIDS Research Consortium Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2001
NCT00013585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Neurologic AIDS Research Consortium (NARC)

Active Ingredients

Drugs in Phase 2 Trials (3)

minocycline (minocin) (1 trial)

prosaptide (1 trial)

selegiline (zelapar) (1 trial)

Drugs in Other Trials (1)

acetylcarnitine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognition Disorders (Phase 2)

HIV Infections (Phase 2)

Nervous System Diseases (Phase 2)

Neuralgia (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4